HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.

Koopman, Timco; van der Vegt, Bert; Dijkstra, Marcel; Bart, Joost; Duiker, Evelien; Wisman, G Bea A; de Bock, Geertruida H; Hollema, Harry

Koopman, Timco; van der Vegt, Bert; Dijkstra, Marcel; Bart, Joost; Duiker, Evelien; Wisman, G Bea A; de Bock, Geertruida H; Hollema, Harry.

Afiliação

Koopman T; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
van der Vegt B; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Dijkstra M; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Bart J; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Duiker E; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Wisman GBA; Department of Gynaecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
de Bock GH; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Hollema H; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Histopathology ; 73(5): 852-863, 2018 Nov.

Article em En | MEDLINE | ID: mdl-29989198

Assuntos

Adenocarcinoma de Células Claras/metabolismo; Neoplasias do Endométrio/metabolismo; Imuno-Histoquímica/métodos; Neoplasias Ovarianas/metabolismo; Receptor ErbB-2/análise; Adenocarcinoma de Células Claras/patologia; Adulto; Idoso; Idoso de 80 Anos ou mais; Anticorpos Monoclonais; Biomarcadores Tumorais/análise; Neoplasias do Endométrio/patologia; Feminino; Humanos; Hibridização In Situ; Pessoa de Meia-Idade; Neoplasias Ovarianas/patologia; Receptor ErbB-2/biossíntese

Palavras-chave

endometrial cancer; human epidermal growth factor 2 (HER2); immunohistochemistry (IHC); in-situ hybridisation (ISH); ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Imuno-Histoquímica / Neoplasias do Endométrio / Adenocarcinoma de Células Claras / Receptor ErbB-2 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Histopathology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google